Anzeige
Mehr »
Login
Donnerstag, 07.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
4.000 Meilen, um herauszufinden, warum der „Warren Buffett des Bergbaus“ in diese Kupferaktie investierte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DXS6 | ISIN: US1711261057 | Ticker-Symbol:
NASDAQ
06.11.24
21:42 Uhr
0,624 US-Dollar
-0,019
-3,01 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
CHROMOCELL THERAPEUTICS CORP Chart 1 Jahr
5-Tage-Chart
CHROMOCELL THERAPEUTICS CORP 5-Tage-Chart

Aktuelle News zur CHROMOCELL THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
24.10.Chromocell announces amendment to stock repurchase plan1
24.10.Chromocell boosts stock buyback plan to $750,0001
24.10.Chromocell Therapeutics Corporation: Chromocell Announces Amendment to Stock Repurchase Plan1
24.10.Chromocell Therapeutics Corp - 8-K, Current Report1
16.09.Chromocell therapeutics director buys $9.8k in stock1
16.09.Chromocell therapeutics CEO buys $5,044 in company stock1
12.09.Chromocell Therapeutics CEO buys shares worth over $10,0001
13.08.Chromocell Therapeutics Corp - 10-Q, Quarterly Report1
07.08.Chromocell Therapeutics Corp - 8-K, Current Report-
07.08.Chromocell announces stock repurchase plan1
07.08.Chromocell Therapeutics Corporation: Chromocell Announces Stock Repurchase Plan1
29.07.Chromocell Therapeutics Corp - S-1, General form for registration of securities1
29.07.Chromocell Therapeutics Corp - 8-K, Current Report1
15.07.Chromocell Corporation: Chromocell to Participate in the Virtual Investor Lunch Break Series1
13.05.Chromocell Corporation: Chromocell To Present at Alliance Global Partner's Healthcare Company Showcase on Tuesday, May 21, 20241
17.04.Pre-market Movers: INVO Bioscience, iLearningEngines, Vanda Pharmaceuticals, CXApp, Chromocell Therapeutics533LOWELL (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.45 A.M. ET).In the Green INVO Bioscience, Inc. (INVO) is up over 73% at $1.35. Vanda...
► Artikel lesen
09.04.Chromocell Corporation: Chromocell Issues Letter to Stockholders from Chief Executive Officer281FREEHOLD, N.J., April 09, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation ("Chromocell", or the "Company"), (NYSE American: CHRO), a pioneer in the development of non-opioid pain treatment...
► Artikel lesen
18.03.Chromocell Corporation: Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023171FREEHOLD, N.J., March 18, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. ("Chromocell", or the "Company"), (NYSE American: CHRO), a pioneer in the development of non-opioid pain treatment...
► Artikel lesen
21.02.Chromocell Corporation: Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 Million227FREEHOLD, N.J., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (NYSE American: CHRO) ("Chromocell", "our", "us" or the "Company"), a clinical-stage biotech company focused on...
► Artikel lesen
16.02.Chromocell Therapeutics Announces Pricing Of $6.6 Mln Initial Public Offering579WASHINGTON (dpa-AFX) - Chromocell Therapeutics Corp. (CHRO) announced the pricing of its initial public offering of 1,100,000 shares of common stock at $6.00 per share on Friday. This offering...
► Artikel lesen
Seite:  Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1